Antithrombotic therapy in patients with atrial fibrillation treated with oral anticoagulation undergoing percutaneous coronary intervention: a North American perspective …

DJ Angiolillo, SG Goodman, DL Bhatt, JW Eikelboom… - Circulation, 2018 - Am Heart Assoc
The optimal antithrombotic treatment regimen for patients with atrial fibrillation undergoing
percutaneous coronary intervention with stent implantation represents a challenge in clinical …

2018 focused update of the Canadian Cardiovascular Society guidelines for the management of atrial fibrillation

JG Andrade, A Verma, LB Mitchell, R Parkash… - Canadian Journal of …, 2018 - Elsevier
Abstract The Canadian Cardiovascular Society (CCS) Atrial Fibrillation Guidelines
Committee provides periodic reviews of new data to produce focused updates that address …

The 2020 Canadian Cardiovascular Society/Canadian Heart Rhythm Society comprehensive guidelines for the management of atrial fibrillation

JG Andrade, M Aguilar, C Atzema, A Bell… - Canadian Journal of …, 2020 - Elsevier
Abstract The Canadian Cardiovascular Society (CCS) atrial fibrillation (AF) guidelines
program was developed to aid clinicians in the management of these complex patients, as …

Perioperative management of antithrombotic therapy: an American College of Chest Physicians clinical practice guideline

JD Douketis, AC Spyropoulos, MH Murad, JI Arcelus… - Chest, 2022 - Elsevier
Background The American College of Chest Physicians Clinical Practice Guideline on the
Perioperative Management of Antithrombotic Therapy addresses 43 Patients-Interventions …

[HTML][HTML] Antithrombotic therapy for atrial fibrillation with stable coronary disease

S Yasuda, K Kaikita, M Akao, J Ako… - … England Journal of …, 2019 - Mass Medical Soc
Background There are limited data from randomized trials evaluating the use of
antithrombotic therapy in patients with atrial fibrillation and stable coronary artery disease …

Canadian Cardiovascular Society 2022 guidelines for peripheral arterial disease

BL Abramson, M Al-Omran, SS Anand… - Canadian Journal of …, 2022 - Elsevier
Patients with widespread atherosclerosis such as peripheral artery disease (PAD) have a
high risk of cardiovascular and limb symptoms and complications, which affects their quality …

Dual antiplatelet therapy duration based on ischemic and bleeding risks after coronary stenting

F Costa, D Van Klaveren, F Feres, S James… - Journal of the American …, 2019 - jacc.org
Background: Complex percutaneous coronary intervention (PCI) is associated with higher
ischemic risk, which can be mitigated by long-term dual antiplatelet therapy (DAPT) …

Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention

D Capodanno, R Mehran, M Valgimigli… - Nature Reviews …, 2018 - nature.com
In patients with manifestations of cardiovascular disease, acetylsalicylic acid (popularly
known as aspirin) has been the mainstay of treatment for decades owing to its capacity to …

2019 Canadian Cardiovascular Society/Canadian Association of Interventional Cardiology guidelines on the acute management of ST-elevation myocardial infarction …

GC Wong, M Welsford, C Ainsworth, W Abuzeid… - Canadian Journal of …, 2019 - Elsevier
Rapid reperfusion of the infarct-related artery is the cornerstone of therapy for the
management of acute ST-elevation myocardial infarction (STEMI). Canada's geography …

Association of ticagrelor vs clopidogrel with major adverse coronary events in patients with acute coronary syndrome undergoing percutaneous coronary intervention

RD Turgeon, SL Koshman, E Youngson… - JAMA internal …, 2020 - jamanetwork.com
Importance Guidelines currently recommend ticagrelor over clopidogrel for patients with
acute coronary syndrome (ACS) based on randomized clinical trial data in which ticagrelor …